Overview

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Status:
RECRUITING
Trial end date:
2029-04-09
Target enrollment:
Participant gender:
Summary
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Phase:
PHASE1
Details
Lead Sponsor:
AstraZeneca